Home301333 • SHE
add
R&G PharmaStudies Co Ltd
Previous close
¥44.08
Day range
¥43.25 - ¥46.18
Year range
¥37.19 - ¥81.38
Market cap
4.23B CNY
Avg Volume
2.33M
P/E ratio
28.10
Dividend yield
0.34%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 177.33M | 10.19% |
Operating expense | 45.03M | 19.80% |
Net income | 23.05M | -19.95% |
Net profit margin | 13.00 | -27.33% |
Earnings per share | — | — |
EBITDA | 27.72M | 21.10% |
Effective tax rate | 12.35% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.70B | 10.38% |
Total assets | 2.21B | 14.87% |
Total liabilities | 431.18M | 44.09% |
Total equity | 1.78B | — |
Shares outstanding | 96.04M | — |
Price to book | 2.39 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 23.05M | -19.95% |
Cash from operations | 23.30M | 30.95% |
Cash from investing | -194.61M | 10.43% |
Cash from financing | -9.25M | -220.84% |
Net change in cash | -180.42M | 11.31% |
Free cash flow | — | — |
About
Founded
Aug 22, 2008
Website
Employees
2,042